Individual Study / de Vathaire_Br J Cancer_1997

de Vathaire_Br J Cancer_1997

de Vathaire_Br J Cancer_1997

Initiatives -
To study the risks of solid tumours and leukaemia after administration of Iodine 131. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
1989
End Year
1995
Funding
e Association pour la Recherche sur le Cancer, the Ligue Nationale Contre le Cancer (Comites de la Mame, des Ardennes et de l'Aube), the Fondation de France (Leg Doris Levy), COGEMA and FRAMATOME. Cecilia Francese received a fellowship from the Program of Radioprotection of the European Communities (no. B 17-913002).

Members

Download
Investigators Contacts
  • Dr. Florent de Vathaire
    National Institute of Health and of Medical Research- INSERM

Design

Study design
Patients' cohort
Follow Up
Mean follow-up of 10 years,
Supplementary Information

Marker Paper

de Vathaire, F; Schlumberger, M; Delisle, MJ; Francese, C; Challeton, C; de la Genardiére, E; Meunier, F; Parmentier, C; Hill, C; Sancho-Garnier, H (1997). Leukaemias and cancers following iodine-131 administration for thyroid cancer. British Journal of Cancer, 75(5), 734–739. doi:10.1038/bjc.1997.130

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
1,771
Number of participants with biosamples
Supplementary Information
Patients treated for a differentiated thyroid cancer in the two participating institutions between 1950 and December 1989 were studied.

Access

Availability of data and biosamples

Data
Biosamples
Other